14K prolactin derived 14‐mer antiangiogenic peptide targets bradykinin‐/nitric oxide‐cGMP‐dependent angiogenesis
Over the past few decades, VEGF‐targeted antiangiogenic therapy for cancers has gained increasing attention. Nevertheless, there are still several limitations such as the potential resistance mechanisms arising in cancer cells against these therapies and their potential adverse effects. These limita...
        Saved in:
      
    
          | Main Authors: | Jaeok Lee, Pavitra Kumar, Suganya Natarajan, So Hyeon Park, Syamantak Majumder, Lakshmikirupa Sundaresan, Kambadur Muralidhar, Jong‐Soon Choi, Hwa Jeong Lee, Suvro Chatterjee | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | Wiley
    
        2024-12-01 | 
| Series: | FEBS Open Bio | 
| Subjects: | |
| Online Access: | https://doi.org/10.1002/2211-5463.13895 | 
| Tags: | Add Tag 
      No Tags, Be the first to tag this record!
   | 
Similar Items
- 
                
                    Progress on angiogenic and antiangiogenic agents in the tumor microenvironment        
                          
 by: Jian Xu, et al.
 Published: (2024-11-01)
- 
                
                    Alzheimer’s Disease: In Vitro and In Vivo Evidence of Activation of the Plasma Bradykinin-Forming Cascade and Implications for Therapy        
                          
 by: Allen P. Kaplan, et al.
 Published: (2024-12-01)
- 
                
                    Antiangiogenic therapy exerts antitumor effects by altering the tumor microenvironment: bibliometric analysis        
                          
 by: Yuan Kang, et al.
 Published: (2024-12-01)
- 
                
                    Prospects of Antiangiogenic Therapy for Portal Hypertension in Liver Cirrhosis        
                          
 by: D. V. Garbuzenko
 Published: (2018-11-01)
- 
                
                    New approach to modeling of antiangiogenic treatment on the basis of Hahnfeldt et al. model        
                          
 by: Jan Poleszczuk, et al.
 Published: (2011-03-01)
 
       